Managing antibiotic associated diarrhoea, BMJ, 2002. ,
, Jun, vol.8, issue.7350, pp.1345-1351
Antibioticassociated pseudomembranous colitis due to toxin-producing clostridia, N Engl J Med, vol.298, issue.10, pp.531-535, 1978. ,
Epidemiology, risk factors and treatments for antibioticassociated diarrhea. Dig Dis, vol.16, pp.292-307, 1998. ,
The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic, Nature Reviews Gastroenterology & Hepatology, vol.11, issue.8, pp.506-520, 2014. ,
Probiotics in perspective, Gastroenterology, 2010. ,
, , p.4
Probiotics: Preventing Antibiotic-Associated Diarrhea, Journal for Specialists in Pediatric Nursing, vol.15, issue.2, pp.160-162, 2010. ,
Systematic review with meta-analysis: Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea, Aliment Pharmacol Ther, vol.42, issue.7, pp.793-801, 2015. ,
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement, BMJ, 2009. ,
, Cochrane Handbook for Systematic Reviews of Interventions
, Available from: /handbook
Améliorer les pratiques et l'organisation des soins : méthodologie des revues systématiques, Sante Publique, 2014. ,
Grey literature in meta-analyses of randomized trials of health care interventions. Cochrane Database Syst Rev, p.10, 2007. ,
CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials, BMJ, vol.340, p.332, 2010. ,
Assessing the quality of reports of randomized clinical trials: is blinding necessary?, Control Clin Trials, vol.17, issue.1, pp.1-12, 1996. ,
Traduction française des lignes directrices PRISMA pour l'écriture et la lecture des revues systématiques et des méta-analyses. Kinésithérapie, la Revue, vol.15, pp.39-44, 2015. ,
,
, Saccharomyces boulardii to Prevent Antibiotic-Associated Diarrhea: A Randomized, Double-Masked, Placebo-Controlled Trial. Open Forum Infect Dis, 2016.
Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea in children: a randomized double-blind placebo-controlled trial, Aliment Pharmacol Ther, vol.21, issue.5, pp.583-90, 2005. ,
Efficacy and safety of Saccharomyces boulardii in prevention of antibiotic-associated diarrhoea due to Helicobacterpylori eradication, Eur J Gastroenterol Hepatol, vol.17, issue.12, pp.1357-61, 2005. ,
Prevention of beta-lactam-associated diarrhea by Saccharomyces boulardii compared with placebo, Am J Gastroenterol, vol.90, issue.3, pp.439-487, 1995. ,
,
, Saccharomyces boulardii for the prevention of antibiotic-associated diarrhea in adult hospitalized patients: a single-center, randomized, double-blind, placebo-controlled trial, Am J Gastroenterol, vol.107, issue.6, pp.922-953, 2012.
Efficacy and safety of Saccharomyces boulardii in the 14-day triple anti-Helicobacter pylori therapy: a prospective randomized placebo-controlled double-blind study, Helicobacter, vol.12, issue.4, pp.309-325, 2007. ,
Prophylactic Saccharomyces boulardii in the prevention of antibiotic-associated diarrhea: a prospective study, Med Sci Monit, vol.12, issue.4, pp.19-22, 2006. ,
Effect of different probiotic preparations on anti-helicobacter pylori therapy-related side effects: a parallel group, triple blind, placebo-controlled study, Am J Gastroenterol, vol.97, issue.11, pp.2744-2753, 2002. ,
The lack of therapeutic effect of Saccharomyces boulardii in the prevention of antibiotic-related diarrhoea in elderly patients, J Infect, vol.36, issue.2, pp.171-175, 1998. ,
Prevention of antibiotic-associated diarrhea by Saccharomyces boulardii: a prospective study, Gastroenterology, vol.96, issue.4, pp.981-989, 1989. ,
Effects of probiotics or broccoli supplementation on Helicobacter pylori eradication with standard clarithromycin-based triple therapy, Korean J Intern Med, 2019. ,
The probiotic effect of Saccharomyces boulardii in a pediatric age group, J Trop Pediatr, vol.50, issue.4, pp.234-240, 2004. ,
Prevention and treatment of diarrhoea with Saccharomyces boulardii in children with acute lower respiratory tract infections, Benef Microbes, vol.4, issue.4, pp.329-363, 2013. ,
, Clinical Risk Factors for Severe Clostridium Difficile-Associated Disease -PubMed, 2020.
Clostridium difficile-associated diarrhea and chronic renal insufficiency, South Med J, vol.95, issue.7, pp.681-684, 2002. ,
Chronic kidney disease as a risk factor for Clostridium difficile infection, Nephrology ,
Safety of probiotics in patients receiving nutritional support: a systematic review of case reports, randomized controlled trials, and nonrandomized trials, Am J Clin Nutr, vol.91, issue.3, pp.687-703, 2010. ,
, Saccharomyces boulardii (ultra-levure) : ajout d'une contre-indication chez les patients en état critique ou immunodéprimés -Lettres aux professionnels de santé -ANSM : Agence nationale de sécurité du médicament et des produits de santé, 2020.
, Invasive infections due to Saccharomyces boulardii (Ultra-levure), Prescrire Int, vol.16, issue.89, p.110, 2007.
Systematic review with meta-analysis: Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea, Aliment Pharmacol Ther, vol.42, issue.7, pp.793-801, 2015. ,
Systematic review and meta-analysis of Saccharomyces boulardii in adult patients, World J Gastroenterol, vol.16, issue.18, pp.2202-2224, 2010. ,
Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease, Am J Gastroenterol, vol.101, issue.4, pp.812-834, 2006. ,
Probiotics in the prevention of antibiotic-associated diarrhea in children: A meta-analysis of randomized controlled trials, The Journal of Pediatrics, vol.149, issue.3, pp.367-372, 2006. ,
Dose-response efficacy of a proprietary probiotic formula of Lactobacillus acidophilus CL1285 and Lactobacillus casei LBC80R for antibiotic-associated diarrhea and Clostridium difficile-associated diarrhea prophylaxis in adult patients, Am J Gastroenterol, vol.105, issue.7, pp.1636-1677, 2010. ,